The Company

PerfAction Technologies, the original developer and undisputed market leader in intradermal remodeling, is pioneering new treatment modalities for aesthetics and dermatological applications. The EnerJet2.0 and AirGent2.0 platforms bring together the company’s proprietary Jet Volumetric Remodeling (JVR) technology, that simultaneously delivers Kinetic Energy and a Healing Compound, to create a unique micro-trauma profile and optimal spread of the compound.

The Medical Aesthetics market is growing a double digit rate, but markets are saturated with Lasers, IPLs, RFs and more. JVR technology offers an innovative new approach that is a synergy between injectables and devices. This energetic innovation provides for a non-surgical facelift solution, a simple neck lines treatment and an exceptional acne scars elimination treatment.

JVR technology is versatile and effective. It allows development of a single platform with numerous indications. While EnerJet2.0 currently offers a range of solutions in aesthetic medicine, there is an extensive clinical research for new indications from both dermatologic and other disciplines.

EnerJet2.0 and JVR technology are ushering in a new era in aesthetic medicine and intradermal compound delivery.



Tim Cranko, CEO

Tim has over 25 years of business development and senior management experience including in CEO and Board member positions in the medical device, pharma and food industries. CEO positions have included in DiverseyLever (a Unilever subsidiary), Pharm-Up – Novolog (Israel’s largest pharmaceuticals and medical device distributor), Novartis OTC (Israel), and AB Dental (a dental implants manufacturer).

Prof. Daniel Cassuto, Medical Director

Plastic Surgeon and a professor of Plastic, Reconstructive and Aesthetic Surgery. He runs a private practice in Milan and serves at the Plastic Surgery Department, University Hospital of Modena, focusing on the treatment of complications from the use of dermal fillers.


Amir Gal, VP Global Sales

Amir has over 20 years of experience as a senior level sales executive with proven success in a broad variety of management positions within local and global companies. Experienced in delivering sustained revenue and growth within competitive markets.  Before joining the EnerJet team, Amir served as VP Sales at Lumenis – Pollogen, Syneron Candela, Cutera Inc., Sharplight and Ultrashape.

Shiri Moskovich, CPA, Chief Financial Officer

Shiri is a Certified Public Accountant with an MBA degree specialization in finance and over a decade of experience working with both privately-held and publically-traded companies. Before joining the EnerJet team, she worked at Price Waterhouse, gaining extensive experience in accounting, maintaining and auditing financial records, managing budgets, risk assessment and business strategy.


Hagai Sroussi, Vice President R&D

With a degree in mechanical Engineering from the prestigious Technion-Israel institute of Technology, Hagai brings valuable expertise and experience to the EnerJet team in multi-disciplinary R&D and product development, specializing in medical devices.

Ziv Toledano, Chief Operating Officer

Ziv joined the EnerJet team in 2010 as the Service Director, before he quickly moved on to become the Manufacturing Manager. He held that position for four years, leading development, implementation and integration teams through development and launch of the company’s products.


Dr. Yuri Vinshtok, Director of Clinical Research

Dr. Yuri Vinshtok currently serves as Clinical Research Director at PerfAction Technologies. For the past ten years, Dr. Vinshtok held clinical management positions in various medical device and pharma companies including Deep Breathe, Medispec, Urogen (former TheraCoat). Dr. Yuri Vinshtok graduated from the medical school (Russia) in 1984 and brings over 20 years of experience in practical medicine. In addition, he holds Master of Public Administration degree from the City University of New York (USA).

Board of Directors


Amit Meridor, Chairman

Amit brings over 20 years of extensive experience at senior executive level in international companies. With his vast experience in various CEO and President roles, Amit shows proven expertise in management, strategic planning and operation. Over the years, Amit has built world-class professional teams, achieved measurable financial performance objectives (including aggressive sales objectives) and led companies through special situations and turnaround programs, all with his visionary entrepreneurial style combined with leadership and creative management skills.

Amnon Harari

Amnon Harari is the head of the space administration in the Defense Ministry. Amnon had joined PerfActions Board of Directors in 2011. Before, he served as Lumenis SVP R&D and VP Sales & Service EMEA. Amnon holds a degree in Physics and has years of experience in medical devices research and development, service and sales.


Shai Levy

Mr. Shai Levy has been the CEO of ProSeed Venture Capital Fund Ltd (traded on the Tel Aviv Stock Exchange as TLV:PRSD) since 2012. Mr. Levy has a key role in managing ProSeed fund’s investments, deal flow, financing and M&A as well as serving on a variety of companies Board of Directors in a wide range of industries.

Mr. Levy gained broad-based management experience with investments in the U.S, Europe and Israel in various sectors mostly focusing on High-Tech, Real Estate and Family Office.

Prior to Joining ProSeed, Mr. Levy served as the Chief Financial & Investment Officer for the Tahari Family in New York for over 5 years, as Director of Financial Reporting & Compliance at the Deutsch Inc, New York (a part of Interpublic Group NYSE:IPG), auditor at PwC, New York and at Ernst and Young Israel.

Mr. Levy holds a Bachelor’s degree in Accounting and Finance from Tel-Aviv University and is a Certified Public Accountant (CPA) in Israel.

Dr. Adina Makover

Dr. Adina Makover currently holds the position of Director of Life Sciences Investments at Proseed VC and serves as a director of the board at several public and private companies. Previously, Dr. Makover has been the managing director of Tzina Bio Perspective, a private investment company focusing on biotechnology and medical device ventures. The investment career follows senior management positions in biotech and device companies, focusing on drugs, diagnostics and tissue engineering, holding positions of CEO, R&D, process development and production manager.

Dr. Makover holds a joint PhD degree in life sciences from Columbia University (USA) and Weizmann Institute of Science (Israel) and performed post-doctoral research at the Weizmann Institute of Science. Dr. Makover also holds an MBA degree from Bar-Ilan University.


Yacha Sutton

Yacha brings to PerfAction over 30 years’ experience in the field of Medical Equipment. In 1981 assisted in the IPO of Laser Industries on Nasdaq and joined the Board of Directors and the Executive Committee of the Company. In 1990 joined Laser Industries as Executive Vice President & CFO and in 1995 was appointed President and COO. Company sold in February 1998 for $270M to ESC Medical Systems. In 1999 was asked to assume the CEO position of ESC Medical Systems. Conducted a major restructuring program and turned the company to profitability in 2000. Led a major acquisition in 2001 of the Coherent Medical Group. In last ten years President of Rugby Investments Ltd, a self owned company that invests in startup companies primarily in Medical Equipment.

A site byrazgroup